About this Event
Admission
- Tickets and Sponsorships availalbe now!
This IN-PERSON event will be hosted on Thursday, May 28, 2026.
International studies led by the Director of the Seaver Autism Center for Research and Treatment, Joseph D. Buxbaum, PhD, MSc, and colleagues, have identified over 250 genes that, if changed, strongly contribute to autism. These discoveries also show that 30% of individuals with profound autism have genetic mutations.
Clinical researchers are now shifting their focus on treatments for autism. Rather than treating all autism as a single entity, we can now begin to look at genetically determined subtypes of autism and consider treatments that are tailored to the genetic subtype. This approach, called precision therapeutics, has revolutionized cancer treatment, and will revolutionize the treatment of profound autism.
Attend the conference to learn how researchers are identifying genetic mutations in autism, how the mutations lead to biologically-determined subtypes of autism, and how preclinical and clinical research are developing and testing new treatments for these subtypes. The interactions between academic scientists, families and advocacy groups, and industry partners will also be discussed, as precision therapeutics requires input from all these groups.
Program
Joseph D. Buxbaum, PhD, MSc
Director, Seaver Autism Center
From Identifying the Causes to Disease Modifying Treatments in Autism: Three Decades of Progress
Robert Komorowski, PhD
Director in Clinical Development, Neurology, Ionis Pharmaceuticals
Efficacy Assessments of Neurodevelopment in Angelman Syndrome
Dominique C. Pichard, MD, MS
Chief Science Officer, International Rett Syndrome Foundation
Nan Yang, PhD
Assistant Professor of Neuroscience, Icahn School at Mount Sinai
More speakers will be announced soon!
Speaker Panel
Recordings of the presentations will be made available online following the conference.
While we will be able to provide verification of attendance, we will NOT be able to offer formal CME credit.
About the Advances in Autism Conference
The annual Conference is a one-day event hosted by the Seaver Autism Center for Research and Treatment at Mount Sinai. It includes a series of lectures given by accomplished professionals in the field of autism. The purpose of the conference is to discuss recent advances in autism - the causes, symptoms, and current and future treatments - with attendees. Conference attendees include practicing psychiatrists, neurologists, psychologists, geneticists, other health care professionals, neuroscientists, educators, family members and social workers.
Donation
If you are able, please consider to the Seaver Autism Center.
This gift will support the Seaver Center’s mission to provide affordable educational opportunities to the public to learn new and improved approaches to caring for people with autism.
If you would like to mail your donation, please mail a check to:Mount Sinai Health System, Attn: Patricia Carchi, One Gustave L. Levy Place, Box 1049, New York, NY 10029-6574
Icahn School of Medicine is a registered 501(c)3 nonprofit and contributions are tax-deductible the extent permitted by law. Tax-ID# 13-6171197 Please email [email protected] or contact Sarah Lynch at 212-241-0349 if you have any questions.
Event Venue & Nearby Stays
New York Academy of Medicine, 1216 5th Avenue, New York, United States
USD 0.00 to USD 10672.57
